Status:
COMPLETED
Effect of Selective iNOS Inhibition During Human Endotoxemia
Lead Sponsor:
Radboud University Medical Center
Conditions:
Endotoxemia
Eligibility:
All Genders
18-35 years
Phase:
PHASE1
Brief Summary
Sepsis or endotoxemia is manifested by hypotension, resistance to vasopressors, myocardial depression,and altered organ blood flow distribution. The mechanisms underlying the cardiovascular dysfunctio...
Eligibility Criteria
Inclusion
- Healthy volunteers
Exclusion
- tendency towards fainting
- alcohol abuse
- nicotine abuse
- drugs abuse
Key Trial Info
Start Date :
January 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2005
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT00184990
Start Date
January 1 2005
End Date
September 1 2005
Last Update
April 15 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Radboud University Nijmegen Medical Centre
Nijmegen, Gelderland, Netherlands, 6500HB